CANCER CHEMOTHERAPY AND PHARMACOLOGY

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

CANCER CHEMOTH PHARM

ISSN / eISSN

0344-5704 / 1432-0843

Aims and Scope

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

Subject Area

PHARMACOLOGY & PHARMACY

ONCOLOGY

CiteScore

6.20

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Pharmacology (medical)	Q1	#58/260
Medicine - Toxicology	Q2	#37/124
Medicine - Oncology	Q2	#122/366
Medicine - Pharmacology	Q2	#104/301
Medicine - Cancer Research	Q2	#100/214

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
ONCOLOGY - SCIE	Q3
PHARMACOLOGY & PHARMACY - SCIE	Q3

H-index

100

Country/Area of Publication

UNITED STATES

Publisher

Springer Berlin Heidelberg

Publication Frequency

Monthly

Year Publication Started

1978

Annual Article Volume

115

Open Access

Contact

SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Popular journals in the same field
Recent articles

A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?: (2023) Angeline Ginzac, Emilie Thivat, Caroline Petorin, Damien Richard, Pauline Herviou, Ioana Molnar, Hervé Devaud, Isabelle Creveaux, Florent Ferrer, Nico...

Effect of vitamin E on doxorubicin and paclitaxel-induced memory impairments in male rats: (2023) Ahmad A. Altarifi, Kareem Sawali, Karem H. Alzoubi, Tareq Saleh, Malik Abu Al-Rub, Omar Khabour

Association between chemotherapy-induced myelosuppression and curative efficacy of 2-cycle chemotherapy in small cell lung cancer: (2023) Xinyu Wang, Shujun Gu, Jingli Wen, Lixi Zhang, Xu Qi

The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis: (2023) Yukio Tonozuka, Hiroshi Tanaka, Kazumi Nomura, Kazuya Sakaguchi, Junpei Soeda, Yoshihide Kakimoto

Pharmacokinetic drug–drug interaction between olaparib and apixaban: a case report: (2023) M. Berge, J. S. Giraud, S. De Percin, A. Puszkiel, A. Thomas-Schoemann, B. Blanchet

Are novel oral oncolytics underdosed in obese patients?: (2023) Lishi Lin, Ellen K. O. van der Meer, Neeltje Steeghs, Jos H. Beijnen, Alwin D. R. Huitema

Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer: (2023) Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi Ando

Prediction of ROS1 and TRKA/B/C occupancy in plasma and cerebrospinal fluid for entrectinib alone and in DDIs using physiologically based pharmacokinetic (PBPK) modeling approach: (2023) Liangang Chen, Na Yao, Hongjie Yang, Shaofeng Zhang, Kai Zhang

Bidirectional pharmacokinetic drug interactions between olaparib and metformin: (2023) Joanna Stanisławiak-Rudowicz, Agnieszka Karbownik, Danuta Szkutnik-Fiedler, Filip Otto, Tomasz Grabowski, Anna Wolc, Edmund Grześkowiak, Edyta Szałek

Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer: (2023) Marie Lambert, Mathieu Alonso, Caroline Munzer, Marie-Christine Zimoch, Laurence Malard, Marion Gambart, Marie-Pierre Castex, Carla Martins, Marlène P...

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation